Daegu, South Korea

Sungwoo Lee

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daegu-Gyeongbuk Medical Innovation Foundation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sungwoo Lee. Retrieved from https://idiyas.com/inventor/sungwoo-lee-ehhfjdni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 27.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sungwoo Lee: A Pioneer in Cancer Treatment

Introduction: Sungwoo Lee, an accomplished inventor based in Daegu, South Korea, has made significant strides in the field of pharmaceutical science. With one patented innovation, he has contributed meaningfully to strategies for preventing and treating cancer. His work exemplifies the impact that a dedicated researcher can have on public health.

Latest Patents: Sungwoo Lee's noteworthy patent is centered around an imidazopyridine derivative, along with its method of preparation and its use in pharmaceutical compositions for cancer treatment. This innovative compound has demonstrated efficacy in inhibiting cancer-related kinases, which play a crucial role in cancer cell proliferation. The patent details not only its utility in treating various forms of cancer but also its potential application in managing Src and Fyn related diseases, including diabetic nephropathy. These multifaceted benefits underline the compound's promise in contributing to advanced therapeutic regimes.

Career Highlights: Currently, Sungwoo Lee is a part of the Daegu-Gyeongbuk Medical Innovation Foundation. Through his association with this esteemed institution, he has focused on developing effective treatments that harness the potential of novel pharmaceutical compounds. His inventiveness in creating the imidazopyridine derivative showcases his commitment to advancing medical science.

Collaborations: Throughout his career, Sungwoo Lee has collaborated with notable colleagues such as Hwan Geun Choi and Jung Beom Son. Together, they have worked on various research projects that aim to enhance the understanding and treatment of complex diseases, highlighting the importance of teamwork in achieving innovation in the medical field.

Conclusion: Sungwoo Lee stands as a testament to the power of innovation and the crucial role that inventors play in healthcare advancements. His patent not only offers hope in the fight against cancer but also opens new pathways for addressing other serious health issues. As he continues to develop his research, Sungwoo Lee's contributions are expected to have lasting impacts on medicine and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…